review Open AccessTop 1% cited
Oral Anticoagulant Therapy
CHEST Journal · 2012 · Vol. 141(2) · pp. e44S–e88S
Walter Ageno✉(University of Insubria)Alexander Gallus(Flinders University)Ann K. Wittkowsky(University of Washington)Mark Crowther(St. Joseph’s Healthcare Hamilton)Elaine M. Hylek(Boston University)Gualtiero Palareti(Policlinico S.Orsola-Malpighi)
Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementPharmacogenetics and Drug MetabolismDabigatranRivaroxabanMedicineAnticoagulantDirect thrombin inhibitorAntithromboticIntensive care medicineDiscovery and development of direct thrombin inhibitorsPharmacodynamicsAdverse effect
MeSH terms
RivaroxabanDabigatranAdministration, OralAnticoagulantsAntithrombinsBenzimidazolesDose-Response Relationship, DrugHumansMorpholinesPyridinesSocieties, MedicalThiophenesThrombosisUnited StatesVitamin K
Funding
- Bristol-Myers Squibb
- Sanofi
- National Heart, Lung, and Blood Institute
Citations
1,489
FWCI
100.38
field-weighted impact
References
448
Percentile
100%
vs. same field & year
Citations per year
Cited by
Antithrombotic Therapy for Atrial Fibrillation
CHEST Journal · 2018 · 924 citations
Antithrombotic Therapy for Atrial Fibrillation
CHEST Journal · 2012 · 918 citations
Evidence-Based Management of Anticoagulant Therapy
CHEST Journal · 2012 · 1,243 citations
Antithrombotic Therapy for VTE Disease
CHEST Journal · 2016 · 4,737 citations
Antithrombotic Therapy for VTE Disease
CHEST Journal · 2012 · 6,117 citations
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
European Heart Journal · 2015 · 8,282 citations
References
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Thrombosis and Haemostasis · 1993 · 2,047 citations
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)
Thrombosis and Haemostasis · 2011 · 399 citations
Maternal and fetal sequelae of anticoagulation during pregnancy
The American Journal of Medicine · 1980 · 997 citations
Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
Clinical Pharmacology & Therapeutics · 2005 · 652 citations
Pharmacology and Management of the Vitamin K Antagonists
CHEST Journal · 2008 · 2,096 citations
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
The American Journal of Medicine · 1998 · 776 citations
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
New England Journal of Medicine · 2011 · 9,320 citations
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Thrombosis and Haemostasis · 2010 · 1,372 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.